{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:59:07Z","timestamp":1740146347489,"version":"3.37.3"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T00:00:00Z","timestamp":1531785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["29808"],"award-info":[{"award-number":["29808"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NSERC -Industrial Chair in Pharmacometrics - Novartis, Pfizer and Inventiv Health Clinical","award":["IRC445178"],"award-info":[{"award-number":["IRC445178"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0198090","type":"journal-article","created":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T17:37:44Z","timestamp":1531849064000},"page":"e0198090","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring an alternative explanation for the second phase of viral decay: Infection of short-lived cells in a drug-limited compartment during HAART"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5013-6406","authenticated-orcid":true,"given":"Steven","family":"Sanche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0515-9128","authenticated-orcid":true,"given":"Thibault","family":"Mespl\u00e8de","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy L.","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1017-3442","authenticated-orcid":true,"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahima","family":"Nekka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,7,17]]},"reference":[{"issue":"6629","key":"ref1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/387188a0","article-title":"Decay characteristics of HIV-1-infected compartments during combination therapy","volume":"387","author":"AS Perelson","year":"1997","journal-title":"Nature"},{"issue":"17","key":"ref2","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1097\/QAD.0b013e3282f12377","article-title":"Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase","volume":"21","author":"JM Murray","year":"2007","journal-title":"AIDS"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S2055-6640(20)30930-4","article-title":"HIV-infected cells are frequently clonally expanded after prolonged antiretroviral therapy: implications for HIV persistence","volume":"1","author":"F Maldarelli","year":"2015","journal-title":"J Virus Erad"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1146\/annurev.med.53.082901.104024","article-title":"The challenge of viral reservoirs in HIV-1 infection","volume":"53","author":"JN Blankson","year":"2002","journal-title":"Annu Rev Med"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"e1000906","DOI":"10.1371\/journal.pcbi.1000906","article-title":"Current estimates for HIV-1 production imply rapid viral clearance in lymphoid tissues","volume":"6","author":"RJ De Boer","year":"2010","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1128\/JVI.73.1.855-860.1999","article-title":"Rapid clearance of simian immunodeficiency virus particles from plasma of rhesus macaques","volume":"73","author":"L Zhang","year":"1999","journal-title":"J Virol"},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/aid.2010.0199","article-title":"Short communication: dynamic constraints on the second phase compartment of HIV-infected cells","volume":"27","author":"AM Spivak","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/apc.2014.0173","article-title":"HIV reservoir dynamics in the face of highly active antiretroviral therapy","volume":"29","author":"CT Costiniuk","year":"2015","journal-title":"AIDS Patient Care STDS"},{"issue":"7","key":"ref9","doi-asserted-by":"crossref","first-page":"e1006478","DOI":"10.1371\/journal.ppat.1006478","article-title":"Treatment with integrase inhibitor suggests a new interpretation of HIV RNA decay curves that reveals a subset of cells with slow integration","volume":"13","author":"EF Cardozo","year":"2017","journal-title":"PLoS Pathog"},{"issue":"22","key":"ref10","doi-asserted-by":"crossref","first-page":"14179","DOI":"10.1128\/JVI.79.22.14179-14188.2005","article-title":"Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli","volume":"79","author":"WJ Swiggard","year":"2005","journal-title":"J Virol"},{"issue":"13","key":"ref11","doi-asserted-by":"crossref","first-page":"6557","DOI":"10.1128\/JVI.02321-07","article-title":"Characterization of the early steps of infection of primary blood monocytes by human immunodeficiency virus type 1","volume":"82","author":"V Arfi","year":"2008","journal-title":"J Virol"},{"issue":"7","key":"ref12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00002030-199807000-00008","article-title":"HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1-infected individuals","volume":"12","author":"SR Lewin","year":"1998","journal-title":"AIDS"},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/infdis\/jit308","article-title":"The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence","volume":"208","author":"SA Yukl","year":"2013","journal-title":"J Infect Dis"},{"issue":"6831","key":"ref14","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/35073667","article-title":"Pathways to neuronal injury and apoptosis in HIV-associated dementia","volume":"410","author":"M Kaul","year":"2001","journal-title":"Nature"},{"issue":"20","key":"ref15","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.190065897","article-title":"Influence of follicular dendritic cells on decay of HIV during antiretroviral therapy","volume":"97","author":"WS Hlavacek","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1073\/pnas.1318249111","article-title":"Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues","volume":"111","author":"CV Fletcher","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/jac\/dkw046","article-title":"Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary site","volume":"71","author":"Y Huang","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/jac\/dkr492","article-title":"Antiretroviral drug treatment of CNS HIV-1 infection","volume":"67","author":"A Yilmaz","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1128\/JVI.77.10.5721-5730.2003","article-title":"Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy","volume":"77","author":"LM Frenkel","year":"2003","journal-title":"J Virol"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/jmv.20993","article-title":"Frequent detection of cell-associated HIV-1 RNA in patients with plasma viral load &lt;50 copies\/ml","volume":"79","author":"B Kupfer","year":"2007","journal-title":"J Med Virol"},{"issue":"7588","key":"ref21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nature16933","article-title":"Persistent HIV-1 replication maintains the tissue reservoir during therapy","volume":"530","author":"R Lorenzo-Redondo","year":"2016","journal-title":"Nature"},{"issue":"13","key":"ref22","doi-asserted-by":"crossref","first-page":"7589","DOI":"10.1128\/JVI.00302-14","article-title":"Mutations in HIV-1 reverse transcriptase affect the errors made in a single cycle of viral replication","volume":"88","author":"ME Abram","year":"2014","journal-title":"J Virol"},{"issue":"16","key":"ref23","doi-asserted-by":"crossref","first-page":"9268","DOI":"10.1128\/JVI.00695-14","article-title":"Altered viral fitness and drug susceptibility in HIV-1 carrying mutations that confer resistance to nonnucleoside reverse transcriptase and integrase strand transfer inhibitors","volume":"88","author":"Z Hu","year":"2014","journal-title":"J Virol"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/psp4.12200","article-title":"A Mathematical Model to Predict HIV Virological Failure and Elucidate the Role of Lymph Node Drug Penetration","volume":"6","author":"S Sanche","year":"2017","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/psp4.12069","article-title":"Approaching Pharmacometrics as a Paleontologist Would: Recovering the Links Between Drugs and the Body Through Reconstruction","volume":"5","author":"M Craig","year":"2016","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/15284336.2017.1282578","article-title":"HIV viral kinetics and T cell dynamics in antiretroviral naive persons starting an integrase strand transfer inhibitor and protease inhibitor regimen","volume":"18","author":"MY Karris","year":"2017","journal-title":"HIV Clin Trials"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa051871","article-title":"Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV","volume":"354","author":"JE Gallant","year":"2006","journal-title":"N Engl J Med"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/nm.2892","article-title":"Antiretroviral dynamics determines HIV evolution and predicts therapy outcome","volume":"18","author":"DI Rosenbloom","year":"2012","journal-title":"Nat Med"},{"key":"ref29","unstructured":"Rohatgi A. WebPlotDigitizer v4.0 Austin, Texas, USA2012 [cited 2017 December 12]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/automeris.io\/WebPlotDigitizer\" xlink:type=\"simple\">https:\/\/automeris.io\/WebPlotDigitizer<\/ext-link>."},{"issue":"7","key":"ref30","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm1777","article-title":"Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs","volume":"14","author":"L Shen","year":"2008","journal-title":"Nat Med"},{"issue":"11","key":"ref31","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1128\/AAC.00194-11","article-title":"Population pharmacokinetic\/pharmacogenetic model for optimization of efavirenz therapy in Caucasian HIV-infected patients","volume":"55","author":"A Sanchez","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1128\/AAC.02058-13","article-title":"Population pharmacokinetics of emtricitabine in HIV-1-infected adult patients","volume":"58","author":"E Valade","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1128\/AAC.05317-11","article-title":"Plasma and intracellular population pharmacokinetic analysis of tenofovir in HIV-1-infected patients","volume":"55","author":"G Baheti","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1128\/AAC.00691-12","article-title":"Novel method to assess antiretroviral target trough concentrations using in vitro susceptibility data","volume":"56","author":"EP Acosta","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm.2649","article-title":"A quantitative basis for antiretroviral therapy for HIV-1 infection","volume":"18","author":"BL Jilek","year":"2012","journal-title":"Nat Med"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.1128\/JVI.00127-10","article-title":"Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection","volume":"84","author":"RM Ribeiro","year":"2010","journal-title":"J Virol"},{"issue":"11","key":"ref37","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/00002030-200007280-00003","article-title":"Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication","volume":"14","author":"JP Ioannidis","year":"2000","journal-title":"AIDS"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.0800050105","article-title":"Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy","volume":"105","author":"S Palmer","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"e1002971","DOI":"10.1371\/journal.pcbi.1002971","article-title":"Explaining the determinants of first phase HIV decay dynamics through the effects of stage-dependent drug action","volume":"9","author":"JB Gilmore","year":"2013","journal-title":"PLoS Comput Biol"},{"year":"1989","author":"P \u00c9rdi","key":"ref40"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1600-065X.2010.00921.x","article-title":"Regulation of CD4+ T-cell contraction during pathogen challenge","volume":"236","author":"KK McKinstry","year":"2010","journal-title":"Immunol Rev"},{"issue":"28","key":"ref42","doi-asserted-by":"crossref","first-page":"e7430","DOI":"10.1097\/MD.0000000000007430","article-title":"The investigation of CD4+T-cell functions in primary HIV infection with antiretroviral therapy","volume":"96","author":"Y Sun","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"19","key":"ref43","doi-asserted-by":"crossref","first-page":"9864","DOI":"10.1128\/JVI.00915-10","article-title":"Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication","volume":"84","author":"ME Abram","year":"2010","journal-title":"J Virol"},{"issue":"10","key":"ref44","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1084\/jem.189.10.1545","article-title":"Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA","volume":"189","author":"RD Hockett","year":"1999","journal-title":"J Exp Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev.immunol.17.1.625","article-title":"Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues","volume":"17","author":"AT Haase","year":"1999","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"ref46","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1128\/JVI.77.8.5037-5038.2003","article-title":"A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo","volume":"77","author":"M Markowitz","year":"2003","journal-title":"J Virol"},{"issue":"6","key":"ref47","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/0091270007300951","article-title":"Steady-state pharmacokinetics of emtricitabine and tenofovir disoproxil fumarate administered alone and in combination in healthy volunteers","volume":"47","author":"MR Blum","year":"2007","journal-title":"J Clin Pharmacol"},{"year":"2013","author":"A Agresti","key":"ref48"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0198090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T03:28:48Z","timestamp":1604633328000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0198090"}},"subtitle":[],"editor":[{"given":"Cristian","family":"Apetrei","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,7,17]]},"references-count":48,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0198090","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,7,17]]}}}